Professor Michael Lunn's (UCL Queen Square Institute of Neurology) team identified a "small but significant" rise in cases of Guillain-Barre syndrome after an AstraZeneca vaccine was given in 2021 but added, "There is no way to prove that any one case is 'caused' by a vaccine."
Read: Express